163 related articles for article (PubMed ID: 20200202)
1. Influence of metabolic syndrome on risk stratification in hypertensive patients: differences between 2003 and 2007 ESH-ESC guidelines.
Martell N; Alvarez-Alvarez B; Fernandez-Cruz A
Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):97-103. PubMed ID: 20200202
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
[TBL] [Abstract][Full Text] [Related]
3. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
[TBL] [Abstract][Full Text] [Related]
4. Glucose metabolism in patients with essential hypertension.
García-Puig J; Ruilope LM; Luque M; Fernández J; Ortega R; Dal-Ré R;
Am J Med; 2006 Apr; 119(4):318-26. PubMed ID: 16564774
[TBL] [Abstract][Full Text] [Related]
5. Age and target organ damage in essential hypertension: role of the metabolic syndrome.
Cuspidi C; Meani S; Valerio C; Sala C; Fusi V; Zanchetti A; Mancia G
Am J Hypertens; 2007 Mar; 20(3):296-303. PubMed ID: 17324743
[TBL] [Abstract][Full Text] [Related]
6. Nocturnal non-dipping pattern in untreated hypertensives at different cardiovascular risk according to the 2003 ESH/ESC guidelines.
Cuspidi C; Meani S; Valerio C; Fusi V; Zanchetti A
Blood Press; 2006; 15(1):37-44. PubMed ID: 16492614
[TBL] [Abstract][Full Text] [Related]
7. Influence of metabolic syndrome on hypertension-related target organ damage.
Mulè G; Nardi E; Cottone S; Cusimano P; Volpe V; Piazza G; Mongiovì R; Mezzatesta G; Andronico G; Cerasola G
J Intern Med; 2005 Jun; 257(6):503-13. PubMed ID: 15910554
[TBL] [Abstract][Full Text] [Related]
8. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
10. SCORE model underestimates cardiovascular risk in hypertensive patients: results of the Polish Hypertension Registry.
Szyndler A; Kucharska WA; Dubiela-D Browska AE; Olszanecka A; Widecka J; B Czkiewicz MA; Widecka K; Galas GY; Chlebi Ska I; Sakiewicz W; Gaciong Z; Widecka K; Januszewicz A; Kawecka-Jaszcz K; Narkiewicz K;
Blood Press; 2011 Dec; 20(6):342-7. PubMed ID: 21675828
[TBL] [Abstract][Full Text] [Related]
11. The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects.
Vidal J; Morínigo R; Codoceo VH; Casamitjana R; Pellitero S; Gomis R
Int J Obes (Lond); 2005 Jun; 29(6):668-74. PubMed ID: 15753955
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study.
Navarro J; Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Bonet A; González-Esteban J
Blood Press; 2007; 16(1):20-7. PubMed ID: 17453748
[TBL] [Abstract][Full Text] [Related]
13. Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome.
Sciarretta S; Ferrucci A; Ciavarella GM; De Paolis P; Venturelli V; Tocci G; De Biase L; Rubattu S; Volpe M
Am J Hypertens; 2007 Jul; 20(7):784-91. PubMed ID: 17586414
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension.
Leoncini G; Ratto E; Viazzi F; Vaccaro V; Parodi A; Falqui V; Conti N; Tomolillo C; Deferrari G; Pontremoli R
J Hum Hypertens; 2007 Oct; 21(10):802-7. PubMed ID: 17541383
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damage.
Mulé G; Cottone S; Nardi E; Andronico G; Cerasola G
Minerva Cardioangiol; 2006 Apr; 54(2):173-94. PubMed ID: 16778751
[TBL] [Abstract][Full Text] [Related]
16. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C
J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population.
Strazzullo P; Barbato A; Siani A; Cappuccio FP; Versiero M; Schiattarella P; Russo O; Avallone S; della Valle E; Farinaro E
Metabolism; 2008 Mar; 57(3):355-61. PubMed ID: 18249207
[TBL] [Abstract][Full Text] [Related]
18. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of the metabolic syndrome as influenced by the measure of obesity employed.
Vega GL; Barlow CE; Grundy SM
Am J Cardiol; 2010 May; 105(9):1306-12. PubMed ID: 20403484
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study.
Cuspidi C; Meani S; Valerio C; Fusi V; Catini E; Sala C; Magrini F; Zanchetti A
Blood Press; 2005; 14(1):25-31. PubMed ID: 15823944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
